Reports on the findings of a study concerning the reduction of the risk of extrapyramidal (EP) symptoms and movement problems with the use of risperidone (Risperdal). Comparison of EPS risk from risperidone and haloperidol; Linear relationship between increasing risperidone dose and the use of antiparkinsonian reactions.
No Comments.